Acute and Chronic Disease Reports
Open Access

The Role of Acute Mountain Sickness (ACM): Its Importance, Preventive Measures and its Effects in Human Body

Andrew Maier^{* *}Correspondence: Andrew Maier, Department of Psychiatry, The University of New York, New York, USA, Email:

Author info »

Description

Acute Mountain Sickness (AMS) is a condition that can affect individuals who ascend to high altitudes too quickly. It is a common concern for trekkers, climbers, and tourists visiting mountainous regions. AMS, if not recognized and managed promptly, can lead to severe health complications. This article aims to shed light on AMS, its symptoms, causes, and strategies for prevention.

Symptoms of acute mountain sickness

AMS typically develops within hours to a day or two after reaching high altitudes, generally above 2,500 meters (8,000 feet). The severity of symptoms can vary from mild to severe, and they often include

Headache: A persistent, throbbing headache is one of the earliest and most common signs of AMS. It is often described as a feeling of pressure on the head [1].

Nausea and vomiting: Nausea and vomiting are frequent symptoms, which can contribute to dehydration if not managed properly [2].

Fatigue and weakness: Individuals with AMS may feel excessively tired and weak, making it difficult to continue physical activities [3].

Dizziness and lightheadedness: A sense of dizziness or lightheadedness can be experienced, leading to unsteadiness and difficulty maintaining balance [4].

Insomnia: Difficulty in falling asleep or experiencing disrupted sleep patterns is a common issue at high altitudes.

Loss of appetite: AMS often leads to a reduced appetite, which can contribute to weight loss.

Shortness of breath: As the body struggles to adapt to lower oxygen levels, individuals may experience rapid breathing and shortness of breath, especially during physical exertion.

Swelling: Swelling of the face, hands, and feet, often referred to as peripheral edema, may occur in some cases.

Causes of acute mountain sickness

AMS is primarily caused by the reduced oxygen levels at higher altitudes. At higher elevations, the air pressure decreases, leading to a decrease in the partial pressure of oxygen. As a result, the body receives less oxygen with each breath, which can affect its ability to function optimally. This oxygen deficiency leads to a cascade of physiological responses that can result in AMS. The exact cause is not fully understood, but several factors can increase the risk of developing AMS [5].

Rapid ascent: Climbing or ascending to high altitudes too quickly does not allow the body enough time to acclimatize to the changes in oxygen levels.

Individual sensitivity: Some individuals may be more prone to AMS than others due to genetic or personal factors.

Altitude: AMS is more likely to occur at higher elevations. The risk increases significantly above 2,500 meters (8,000 feet) [6].

Dehydration: Failing to maintain adequate hydration levels can exacerbate AMS symptoms.

Pre-existing medical conditions: Certain medical conditions, such as respiratory disorders or heart problems, can increase the risk of AMS.

Preventing acute mountain sickness

Preventing AMS is essential for a safe and enjoyable mountain experience. Here are some strategies to minimize the risk [7].

Gradual ascent: Ascend to higher altitudes gradually, allowing the body time to acclimatize. Avoid rapid gains in altitude.

Stay hydrated: Drink plenty of fluids to prevent dehydration, but avoid excessive alcohol and caffeine consumption.

Rest: Ensure one gets enough rest and sleep during the ascent [8].

Medication: In some cases, medication such as acetazolamide (Diamox) may be prescribed to help prevent or alleviate symptoms. Consult a healthcare professional for guidance [9].

Descend if symptoms worsen: If AMS symptoms become severe or do not improve, descending to a lower altitude is the most effective treatment [10].

Conclusion

Acute Mountain Sickness is a common concern for those who venture into high-altitude regions. Recognizing the symptoms, understanding its causes, and adopting preventive measures are crucial for a safe and enjoyable mountain experience. By taking precautions and respecting the challenges of high-altitude environments, individuals can reduce the risk of AMS and ensure a memorable adventure in the mountains.

References

1. Saito S, Tobe K, Harada N, Aso C, Nishihara F, Shimada H. Physical condition among middle altitude trekkers in an aging society. Am J Emerg Med. 2002;20(4):291-294.

   [Crossref] [Google Scholar] [PubMed]

2. Aminzadeh F, Dalziel WB. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002;39(3):238-247.

   [Crossref] [Google Scholar] [PubMed]

3. Lipman GS, Kanaan NC, Holck PS, Constance BB, Gertsch JH, PAINS Group. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med. 2012;59(6):484-490.

   [Crossref] [Google Scholar] [PubMed]

4. Ross RT. The random nature of cerebral mountain sickness. Lancet. 1985;325(8435):990-991.

   [Crossref] [Google Scholar] [PubMed]

5. McDevitt M, McIntosh SE, Rodway G, Peelay J, Adams DL, Kayser B. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up. Wilderness Environ Med. 2014;25(2):152-159.

   [Crossref] [Google Scholar] [PubMed]

6. Lipman GS, Pomeranz D, Burns P, Phillips C, Cheffers M, Evans K, et al. Budesonide versus acetazolamide for prevention of acute mountain sickness. Am J Med. 2018;131(2):200-209.

   [Crossref] [Google Scholar] [PubMed]

7. Lipman GS, Jurkiewicz C, Burnier A, Marvel J, Phillips C, Lowry C, et al. A randomized controlled trial of the lowest effective dose of acetazolamide for acute mountain sickness prevention. Am J Med. 2020;133(12):706-715. [Crossref]

   [Google Scholar] [PubMed]

8. Burns P, Lipman GS, Warner K, Jurkiewicz C, Phillips C, Sanders L, et al. Altitude sickness prevention with ibuprofen relative to acetazolamide. American J Med. 2019;132(2):247-251.

   [Crossref] [Google Scholar] [PubMed]

9. Wu Y, Zhang C, Chen Y, Luo YJ. Association between acute mountain sickness (AMS) and age: a meta-analysis. Mil Med Res. 2018;5:1-8.

   [Crossref] [Google Scholar] [PubMed]

10. Shea KM, Ladd ER, Lipman GS, Bagley P, Pirrotta EA, Vongsachang H, et al. The 6-minute walk test as a predictor of summit success on denali. Wilderness Environ Med. 2016;27(1):19-24.

    [Crossref] [Google Scholar] [PubMed]